Ma Rongcai, Shi Leiyu, Sun Gang
Department of Health Management, School of Health Management, Southern Medical University, Guangzhou, Guangdong, 510515, People's Republic of China.
Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, 21205, USA.
Risk Manag Healthc Policy. 2023 Apr 2;16:489-502. doi: 10.2147/RMHP.S402813. eCollection 2023.
The purpose of this study is to evaluate public health measures during the first Omicron wave in Singapore and Israel to inform other countries confronted by COVID-19 outbreaks.
A comparative analysis was conducted using epidemiological data from Singapore and Israel between November 25th, 2021 and May 2nd, 2022 and policy information to examine the effects of public health measures in the two countries during the COVID-19 pandemic.
Public health measures implemented by Singapore and Israel in response to the first Omicron wave were primarily intended to mitigate the effects of the COVID-19 pandemic. In Singapore, the pandemic led to more than 910,000 confirmed cases, a mortality rate of approximately 0.047%, a hospitalization rate of approximately 10.95%, and a severe illness rate of approximately 0.48%, without a second peak. In Israel, the pandemic not only resulted in over 2.74 million confirmed cases, a mortality rate of 0.095%, a hospitalization rate of about 7.39%, and a severe illness rate of approximately 2.30% but also returned after the significant relaxation of prevention regulations from March 1st, 2022.
Early and strict border control measures and surveillance measures are more effective in preventing and controlling the rapid spread of new strains of COVID-19 in the early stage. Furthermore, to prevent and control this highly infectious disease, COVID-19 vaccinations and booster shots must be promoted as soon as possible, medical service capacity must be enhanced, the hierarchical medical system must be improved, and non-pharmacological interventions must be implemented.
本研究旨在评估新加坡和以色列在奥密克戎毒株首次流行期间采取的公共卫生措施,以为其他面临新冠疫情爆发的国家提供参考。
利用2021年11月25日至2022年5月2日期间新加坡和以色列的流行病学数据及政策信息进行对比分析,以考察新冠疫情期间两国公共卫生措施的效果。
新加坡和以色列针对奥密克戎毒株首次流行实施的公共卫生措施主要旨在减轻新冠疫情的影响。在新加坡,疫情导致确诊病例超过91万例,死亡率约为0.047%,住院率约为10.95%,重症率约为0.48%,且未出现第二波高峰。在以色列,疫情不仅导致确诊病例超过274万例,死亡率为0.095%,住院率约为7.39%,重症率约为约2.30%,而且在2022年3月1日预防规定大幅放宽后疫情出现反弹。
早期严格的边境管控措施和监测措施在新冠病毒新毒株传播初期的防控中更为有效。此外,为防控这种高传染性疾病,必须尽快推广新冠疫苗接种和加强针接种,增强医疗服务能力,完善分级医疗体系,并实施非药物干预措施。